International Membership

IT Starts With SITC Membership

LEARN:

Participate in low- or zero-cost educational programming

CONNECT:

Networking and volunteer opportunities to accelerate your career growth

PUBLISH:

Low-or zero-cost processing fees for articles accepted to the Journal for ImmunoTherapy of Cancer (JITC)

ENGAGE:

Numerous opportunities to showcase your research through funding, awards and abstracts

Immunotherapy Resources

SITC 2026 – 41^st Annual Meeting & Pre-Conference Programs

As the largest conference focused solely on cancer immunotherapy, the SITC Annual Meeting & Pre-Conference Programs provides international leaders from academia, regulatory and government agencies, as well as industry representatives, with a multidisciplinary educational and interactive environment focused on improving outcomes for all cancer patients. If you are a researcher, clinician or student in a non-Industry/Biotech setting, and you reside and work/study in a developing economy according to the World Bank, you may be eligible for zero-cost registration to the SITC Annual Meeting & Pre-Conference Programs.

Learn More

SITC OnDemand

SITC OnDemand is a multimedia library that lets you watch content anytime, anywhere. Access more than 1,300 sessions from past SITC events — including Annual Meetings, Spring Scientifics, webinars, and more — with new videos added regularly. The most advantageous way to start streaming? Become a SITC member.

Discover

Special Interest Groups (SIGs)

SITC’s Special Interest Groups (SIGs) are dynamic, collaborative spaces where professionals with shared interests can connect, communicate, and advance the field together. In addition to scientific SIGs, SITC offers Regional SIGs which are online communities of stakeholders with similar interests in expanding global access to IO and promoting international collaboration. Members will work to assess regional education needs and create connections with local organizations to help inform SITC’s educational materials, resource dissemination tactics, and future global efforts.

Find Out More

Increasing Access to IO: A Global Webinar Series

SITC hosted a free-to-attend educational program crafted specifically for international audiences, titled “Increasing Access to IO: A Global Webinar Series”. This series serves as an excellent resource for all stakeholders interested in learning about the application of immunotherapy, as well as the infrastructure and resources needed to support the expansion of access around the globe.

Learn More

Advances in Cancer Immunotherapy™

The Advances in Cancer Immunotherapy™ (ACI) educational series offers focused clinical education on a disease state or topic. Attendees of these half-day, innovative programs get in-depth training in immunotherapy treatment for a variety of topics from experts in the field. The ACI program also features discussions of closed cases submitted from attendees to hear guidance and insights from faculty. These programs are available at zero cost to the attendee.

LEARN MORE

Certificate in Cancer Immunotherapy

The Certificate in Cancer Immunotherapy is offered online via the SITC connectED platform and consists of eight independent learning modules—all approved for CME, CNE, CPE and MOC credits—that can be stacked to earn the SITC Graduate in Cancer Immunotherapy (SITC-G) designation. The SITC-G designation identifies a healthcare provider as completing specialized training in cancer immunotherapy. The SITC-G designation certificate is available to those that are treating physicians (U.S. licensed MD / DO or global equivalent), or practicing licensed NP, PA, PharmD or RPh degree holders involved in direct clinical services, or global equivalent. For learners that do not meet the parameters above, a non-designation certificate track is available, for those who wish to further their immunology/immunotherapy education. Non-designation certificate learners are able to earn CME, CNE, CPE and MOC credit (as available in each module). Each module is available individually. This program is available at zero cost to members residing in low- and lower middle- income countries. 

Discover the Certificate in Cancer Immunotherapy

Spring Scientific

The 2026 SITC Spring Scientific will bring together experts in cell therapy, drug development, and immuno-oncology to address the timely topic of next-generation cellular therapies, T cell engagers, and combination therapies to treat cancer.

Basic, translational, and clinical scientists in attendance will benefit as they learn more about the fast-paced and exciting field of immunometabolism and its impact in the field of cancer immunotherapy. 

Learn More

Journal for ImmunoTherapy of Cancer

The Journal for ImmunoTherapy of Cancer (JITC) is the official journal of the Society for Immunotherapy of Cancer (SITC). This open access, peer-reviewed journal not only serves as the global voice of the society, but also a targeted outlet for the publication of original research articles, literature reviews, position papers and discussion on all aspects of tumor immunology and cancer immunotherapy–from basic research to clinical application. 

JITC offers full waivers for the full Article Processing Charges (APC)–100% discount of the APC–where all authors are based in low-income countries. Requests for waivers must be made prior to submission.

Explore the Journal

Upcoming Events

If you are interested in learning more about upcoming SITC events and collaborative education programs, please visit the SITC event calendar.  

Global Access and Impact Committee

In 2018, the Society for Immunotherapy of Cancer (SITC) Board of Directors prioritized global access to cancer immunotherapy as a strategic goal for the society. To facilitate this goal, SITC formed the Global Access and Impact Committee. This committee, comprising an array of international stakeholders, seeks to develop strategies that overcome the challenges of science, education, policy and infrastructure within low- and lower-middle income economies to promote immunotherapy utilization and access across the world.

World Immunotherapy Council (WIC)

The World Immunotherapy Council (WIC) is an international alliance focused on facilitating rapid development and global dissemination of cancer immunotherapies through scientific exchange. Made up of 29 academic-based, multi-institutional immunotherapy interest groups from around the world, the council works to foster collaboration and share knowledge to promote, critically examine, and further the duality and success of treating cancer with immunotherapeutic practices, with the goal of improving patient outcomes.